mRNA |
brivanib |
CTRPv2 |
pan-cancer |
AAC |
-0.01 |
0.8 |
mRNA |
serdemetan |
FIMM |
pan-cancer |
AAC |
-0.046 |
0.8 |
mRNA |
NVP-BEZ235 |
CTRPv2 |
pan-cancer |
AAC |
-0.012 |
0.8 |
mRNA |
SB-431542 |
CTRPv2 |
pan-cancer |
AAC |
-0.011 |
0.8 |
mRNA |
navitoclax:MST-312 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.01 |
0.8 |
mRNA |
UNC0638 |
GDSC1000 |
pan-cancer |
AAC |
0.008 |
0.8 |
mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0092 |
0.8 |
mRNA |
Irinotecan |
CCLE |
pan-cancer |
AAC |
0.015 |
0.8 |
mRNA |
decitabine |
CTRPv2 |
pan-cancer |
AAC |
0.0074 |
0.8 |
mRNA |
T0901317 |
GDSC1000 |
pan-cancer |
AAC |
-0.0087 |
0.8 |